SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

30 Jul 2007 07:01

Rentokil Initial PLC30 July 2007 30 July 2007 Rentokil Initial to acquire major regional US pest control company Rentokil Initial plc (LSE: RTO) announces that it has entered into an agreementfor the acquisition of the business and assets of Presto-X-Company from itsprivate owners for an initial cash consideration of US$38 million (£19 million)plus further cash consideration of up to $7 million (£3.5 million) based on theactual results for the year to 31 December 2007. Presto-X is a significantregional pest control company based in Omaha, Nebraska, USA, focusedpredominantly on commercial customers. Its turnover for the 12 months to 31December 2006 was US$29 million. Presto-X has 300 employees and operates from 21 branches within the centralstates of the USA including Denver, Dallas, Memphis, St Louis, Kansas City,Chicago and Oklahoma City. It is an excellent operational fit with Rentokil'sexisting North American operations, which operate from 56 branches, primarilyacross the eastern US states. Both organisations are shareholders in Copesan,an alliance of companies created to provide pest management solutions tocustomers with locations across North America. Doug Flynn, Chief Executive of Rentokil Initial, said: "Today's announcement is fully in line with our strategy in North America ofacquiring quality regional companies which expand our footprint, build densityin core regions and improve returns in this growing market. This follows thesuccessful acquisition and integration of JC Ehrlich, America's fourth largestpest control company, in 2006. Our business in North America continues tostrengthen its position in the world's largest pest control market." Ends Notes to Editors Rentokil Initial is one of the largest business services companies in the world,operating in all the major economies of Europe, North America, Asia Pacific andAfrica. The company provides a wide range of support services in over 40countries where the 'Rentokil' and 'Initial' brands represent innovation, deepexpertise and consistent quality of service. Services include textiles andwashroom services, pest control, office plants and artwork, parcels delivery andfacilities services. Rentokil operates pest control services in 38 countries, covering every majoreconomic centre around the world. In 2006, Rentokil Pest Control revenues were£280 million, up 33.7%, of which the USA accounted for 28%. Presto-X management has been at the forefront of the pest control industry inthe USA. Co-owner Ward Combs was previously President of the National PestManagement Association, while Co-owner Jerry Keown was long-time Chairman of theGovernment Affairs Committee of NPMA and was recently honoured for his servicein that capacity. For further information, please contact Rentokil Initial plc Malcolm Padley, Corporate Communications - 020 7866 3027/ 07788 978 199 Lisa Williams, Investor Relations - 020 7866 3028/07980 895 419 Brunswick Group Kate Holgate - 020 7404 5959/07974 982402 Tom Williams - 020 7404 5959/07834 502 361 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
3rd Oct 20222:36 pmRNSBlock listing Interim Review
30th Sep 202211:42 amRNSDirector Declaration
14th Sep 20225:55 pmRNSDirector/PDMR Shareholding
14th Sep 202212:21 pmRNSDirector/PDMR Shareholding
7th Sep 20222:38 pmRNSPublication of Circular-Prospectus & GM Notice
22nd Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20222:02 pmRNSDirector/PDMR Shareholding
28th Jul 20227:00 amRNS2022 Interim Results
27th Jul 20229:54 amRNSDirector Declaration
18th Jul 20223:11 pmRNSHolding(s) in Company
15th Jul 20225:30 pmRNSHolding(s) in Company
15th Jul 202211:57 amRNSHolding(s) in Company
27th Jun 20222:27 pmRNSPost stabilisation notice - Rentokil Initial Plc
22nd Jun 20224:16 pmRNSHolding(s) in Company
21st Jun 20223:37 pmRNSDirector/PDMR Shareholding
20th Jun 20229:12 amRNSPre stabilisation notice - Rentokil Initial Plc
20th May 202210:20 amRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSResult of AGM
21st Apr 20227:00 amRNSQ1 Trading Update
1st Apr 20227:00 amRNSBlock listing Interim Review
31st Mar 20226:15 pmRNSTotal Voting Rights
30th Mar 20229:44 amRNSAnnual Financial Report
29th Mar 20222:20 pmRNSDirector/PDMR Shareholding
25th Mar 20224:31 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSUpdate on Terminix acquisition
14th Mar 202211:00 amRNSAdditional Listing
3rd Mar 20227:00 amRNSFinal Results
2nd Mar 202210:29 amRNSDirector/PDMR Shareholding
28th Feb 20224:47 pmRNSHolding(s) in Company
22nd Dec 20215:38 pmRNSDirector/PDMR Shareholding
21st Dec 20214:09 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSFurther re Terminix Acqn S&P reaffirms BBB rating
15th Dec 20212:02 pmRNSDirector/PDMR Shareholding
14th Dec 20217:00 amRNSAcquisition of Terminix by Rentokil Initial plc
22nd Oct 202110:42 amRNSDirector Declaration
21st Oct 20217:00 amRNSQ3 Trading Update
1st Oct 202110:00 amRNSBlock listing Interim Review
28th Sep 20217:00 amRNSNotice of Capital Markets Day
17th Aug 20216:09 pmRNSDirector/PDMR Shareholding
12th Aug 20214:48 pmRNSDirector/PDMR Shareholding
29th Jul 20217:00 amRNSInterim Results
8th Jul 20217:00 amRNSNotice of termination of guarantee
11th Jun 20211:50 pmRNSNotice of Early Redemption
12th May 20216:03 pmRNSResult of AGM
22nd Apr 20217:00 amRNSQ1 Trading Update
7th Apr 20212:01 pmRNSDirector/PDMR Shareholding
1st Apr 20216:30 pmRNSDirector/PDMR Shareholding
1st Apr 202110:23 amRNSBlock listing Interim Review
1st Apr 202110:16 amRNSChange of Registered Office
31st Mar 20214:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.